drugset / Trial / NCT05836753

Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy

NCT05836753

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study was to evaluate the efficacy and safety of Sarecycline versus placebo in the treatment of microcirculation dysfunction after reperfusion therapy in patients with large vessel occlusion stroke.

Timeline

Start
2023-05-07
Primary completion
2023-11
Completion
2023-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sarecycline Small molecule 100 mg Oral

Indications